Report Detail
Global (United States, European Union and China) Alzheimer’s Disease Therapeutics and Diagnostics Market Research Report 2019-2025
- RnM3623214 |
- 29 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014.
In 2019, the market size of Alzheimer’s Disease Therapeutics and Diagnostics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alzheimer’s Disease Therapeutics and Diagnostics.
This report studies the global market size of Alzheimer’s Disease Therapeutics and Diagnostics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Alzheimer’s Disease Therapeutics and Diagnostics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Eisai
Novartis
Forest Laboratories
TauRx Therapeutics
AC Immune
Johnson & Johnson.
H. Lundbeck
Market Segment by Product Type
Lumbar puncture test
Computed tomography (CT) scan
Magnetic resonance imaging (MRI)
Electroencephalography (EEG)
Positron emission tomography (PET) scan
Others
Market Segment by Application
Marketed Drugs
Pipeline Drugs
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Alzheimer’s Disease Therapeutics and Diagnostics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Alzheimer’s Disease Therapeutics and Diagnostics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Alzheimer’s Disease Therapeutics and Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Lumbar puncture test
- 1.3.3 Computed tomography (CT) scan
- 1.3.4 Magnetic resonance imaging (MRI)
- 1.3.5 Electroencephalography (EEG)
- 1.3.6 Positron emission tomography (PET) scan
- 1.3.7 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2019-2025)
- 1.4.2 Marketed Drugs
- 1.4.3 Pipeline Drugs
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size
- 2.1.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue 2014-2025
- 2.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales 2014-2025
- 2.2 Alzheimer’s Disease Therapeutics and Diagnostics Growth Rate by Regions
- 2.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales by Regions 2014-2019
- 2.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Alzheimer’s Disease Therapeutics and Diagnostics Sales by Manufacturers
- 3.1.1 Alzheimer’s Disease Therapeutics and Diagnostics Sales by Manufacturers 2014-2019
- 3.1.2 Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Manufacturers (2014-2019)
- 3.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
- 3.3 Alzheimer’s Disease Therapeutics and Diagnostics Price by Manufacturers
- 3.4 Key Manufacturers Alzheimer’s Disease Therapeutics and Diagnostics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
- 3.6 Key Manufacturers Alzheimer’s Disease Therapeutics and Diagnostics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Lumbar puncture test Sales and Revenue (2014-2019)
- 4.1.2 Computed tomography (CT) scan Sales and Revenue (2014-2019)
- 4.1.3 Magnetic resonance imaging (MRI) Sales and Revenue (2014-2019)
- 4.1.4 Electroencephalography (EEG) Sales and Revenue (2014-2019)
- 4.1.5 Positron emission tomography (PET) scan Sales and Revenue (2014-2019)
- 4.1.6 Others Sales and Revenue (2014-2019)
- 4.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Type
- 4.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type
- 4.4 Alzheimer’s Disease Therapeutics and Diagnostics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales by Application
6 United States
- 6.1 United States Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Company
- 6.2 United States Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Type
- 6.3 United States Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Application
7 European Union
- 7.1 European Union Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Company
- 7.2 European Union Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Type
- 7.3 European Union Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Application
8 China
- 8.1 China Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Company
- 8.2 China Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Type
- 8.3 China Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Company
- 9.2 Rest of World Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Type
- 9.3 Rest of World Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Application
- 9.4 Rest of World Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Countries
- 9.4.1 Rest of World Alzheimer’s Disease Therapeutics and Diagnostics Sales by Countries
- 9.4.2 Rest of World Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Alzheimer’s Disease Therapeutics and Diagnostics
- 10.1.4 Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Eisai
- 10.2.1 Eisai Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Alzheimer’s Disease Therapeutics and Diagnostics
- 10.2.4 Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction
- 10.2.5 Eisai Recent Development
- 10.3 Novartis
- 10.3.1 Novartis Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Alzheimer’s Disease Therapeutics and Diagnostics
- 10.3.4 Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction
- 10.3.5 Novartis Recent Development
- 10.4 Forest Laboratories
- 10.4.1 Forest Laboratories Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Alzheimer’s Disease Therapeutics and Diagnostics
- 10.4.4 Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction
- 10.4.5 Forest Laboratories Recent Development
- 10.5 TauRx Therapeutics
- 10.5.1 TauRx Therapeutics Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Alzheimer’s Disease Therapeutics and Diagnostics
- 10.5.4 Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction
- 10.5.5 TauRx Therapeutics Recent Development
- 10.6 AC Immune
- 10.6.1 AC Immune Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Alzheimer’s Disease Therapeutics and Diagnostics
- 10.6.4 Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction
- 10.6.5 AC Immune Recent Development
- 10.7 Johnson & Johnson.
- 10.7.1 Johnson & Johnson. Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Alzheimer’s Disease Therapeutics and Diagnostics
- 10.7.4 Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction
- 10.7.5 Johnson & Johnson. Recent Development
- 10.8 H. Lundbeck
- 10.8.1 H. Lundbeck Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Alzheimer’s Disease Therapeutics and Diagnostics
- 10.8.4 Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction
- 10.8.5 H. Lundbeck Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Alzheimer’s Disease Therapeutics and Diagnostics Sales Channels
- 11.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Distributors
- 11.3 Alzheimer’s Disease Therapeutics and Diagnostics Customers
12 Market Forecast
- 12.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Revenue Forecast 2019-2025
- 12.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Type
- 12.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Application
- 12.4 Alzheimer’s Disease Therapeutics and Diagnostics Forecast by Regions
- 12.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Alzheimer’s Disease Therapeutics and Diagnostics. Industry analysis & Market Report on Alzheimer’s Disease Therapeutics and Diagnostics is a syndicated market report, published as Global (United States, European Union and China) Alzheimer’s Disease Therapeutics and Diagnostics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Alzheimer’s Disease Therapeutics and Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
